Vision-Sciences to Present at Lazard Capital Markets 5th Annual Medical
Technology Snowbird Conference
ORANGEBURG, N.Y., Feb. 7, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc.
(Nasdaq:VSCI), a leading provider of unique flexible endoscopic products
utilizing its proprietary sterile disposable EndoSheath® technology, today
announced that Cynthia Ansari, President and Chief Executive Officer, will
participate in the Lazard Capital Markets 5th Annual Medical Technology
The event is being held from February 27 - March 1, 2013 at The Cliff Hotel,
Snowbird Ski and Summer Resort in Snowbird, Utah. The conference format
consists of a full day of one-on-one meetings and will not be webcast.
Institutional investors that wish to request a meeting with Vision-Sciences
should contact Lazard Capital Markets.
About Vision-Sciences, Inc.
Vision-Sciences, Inc. designs, develops, manufactures and markets products for
endoscopy – the science of using an instrument, known as an endoscope, to
provide minimally invasive access to areas not readily available to the human
eye. Vision-Sciences' unique flexible endoscopic products utilize a
streamlined visualization system and proprietary sterile disposable sheaths,
known as EndoSheath technology, to provide users quick, efficient endoscope
turnover while ensuring enhanced patient safety through the use of sterile,
single-use technology. Within its medical segment, Vision-Sciences targets
five main areas for its fiber and video endoscopes and EndoSheath technology:
urology, pulmonology, gastroenterology (GI), ENT (ear, nose and throat) and
spine. Information about Vision-Sciences' products is available at
The Vision-Sciences, Inc. logo is available at
Vision Sciences^®, Slide-On^®, EndoSheath^®, EndoWipe^® and The Vision
System^® are registered trademarks of Vision-Sciences, Inc.
CONTACT: Keith Darragh
VP, Finance and Principal Financial and Accounting Officer
In-Site Communications, Inc.
Press spacebar to pause and continue. Press esc to stop.